apixaban우선순위 중간ICSR 검토기타
LITERATURE DETAIL · PMID 42614334
Apixaban Lead-In Versus Lead-In Omission in Hospitalized Adults with Acute Venous Thromboembolism: A Retrospective Safety Analysis.
Apixaban Lead-In Versus Lead-In Omission in Hospitalized Adults with Acute Venous Thromboembolism: A Retrospective Safety Analysis.
- 저자
- Kelly Rice, Abigail Hoff, Molly Droege, Timothy Rice, Christopher A Droege, Paige Bradshaw
- 저널
- Hospital pharmacy
- 공개일
- 2026 Aug 17
- 연구 유형
- 기타
- DOI
- 10.1177/00185787261476068
문헌 요약
Apixaban for acute venous thromboembolism (VTE) is dosed with an intensified 7-day lead-in to decrease recurrence. The optimal initiation dosing in hospitalized patients remains unknown. This study compares the safety and efficacy of apixaban maintenance versus lead-in dose initiation in hospitalized patients with acute VTE. This IRB-approved, retrospecti…
PV 검토 포인트
개별 증례 가능성과 중대성, 예상성 및 중복 여부를 우선 검토합니다.